Nils Witt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nils Witt has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Bassem Abdel Samad
Department of Cardiology, Karolinska Institute at South Hospital (Södersjukhuset), Stockholm, Sweden
2 shared publications Mahbubul Alam
Department of Cardiology, Karolinska Institute at Danderyd Hospital, Stockholm, Sweden
2 shared publicationsAdam Timmis
Queen Mary University of London, Barts Heart Centre, London, UK
1 shared publication- Adel Aminian
Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Belgium (A.A.).
1 shared publication - Adrian Paul Banning
Oxford Heart Center, Oxford University Hospitals NHS Foundation Trust, United Kingdom (A.P.B.).
1 shared publication - Ahmed Magdy
Chairman of the Egyptian Board of Interventional Cardiology , Cairo
1 shared publication
Latest Publications
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014300
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy
BACKGROUND: The clinical impact of a chronic total occlusion (CTO) in patients with 3-vessel coronary artery disease undergoing fractional flow reserve–guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents or coronary artery bypass grafting (CABG) is unclear. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) compared fractional flow reserve–guided PCI with CABG in patients with 3-vessel coronary artery disease. The primary end point was major adverse cardiac and cerebrovascular events, a composite of death, myocardial infarction, stroke, or repeat revascularization at 1 year. In this substudy, the 3-year outcomes were analyzed in patients with or without a CTO. RESULTS: Of the patients randomized to PCI or CABG in the FAME 3 trial, 305 (21%) had a CTO. In the PCI arm, revascularization of the CTO was attempted in 61% with a procedural success rate of 88%. The incidence of major adverse cardiac and cerebrovascular events at 3 years was not significantly different between those with or without a CTO in both the PCI (15.2% versus 20.1%; adjusted hazard ratio, 0.62 [95% CI, 0.38–1.03]; P =0.07) and the CABG (13.0% versus 12.9%; adjusted hazard ratio, 0.96 [95% CI, 0.55–1.66]; P =0.88) arms. In those without a CTO, PCI was associated with a significantly higher risk of major adverse cardiac and cerebrovascular events compared with CABG (adjusted hazard ratio, 1.61 [95% CI, 1.20–2.17]; P P =0.56; P interaction =0.31). CONCLUSIONS: The presence of a CTO did not significantly impact the treatment effect of PCI versus CABG at 3 years in patients with 3-vessel coronary artery disease. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02100722.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014300
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy
BACKGROUND: The clinical impact of a chronic total occlusion (CTO) in patients with 3-vessel coronary artery disease undergoing fractional flow reserve–guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents or coronary artery bypass grafting (CABG) is unclear. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) compared fractional flow reserve–guided PCI with CABG in patients with 3-vessel coronary artery disease. The primary end point was major adverse cardiac and cerebrovascular events, a composite of death, myocardial infarction, stroke, or repeat revascularization at 1 year. In this substudy, the 3-year outcomes were analyzed in patients with or without a CTO. RESULTS: Of the patients randomized to PCI or CABG in the FAME 3 trial, 305 (21%) had a CTO. In the PCI arm, revascularization of the CTO was attempted in 61% with a procedural success rate of 88%. The incidence of major adverse cardiac and cerebrovascular events at 3 years was not significantly different between those with or without a CTO in both the PCI (15.2% versus 20.1%; adjusted hazard ratio, 0.62 [95% CI, 0.38–1.03]; P =0.07) and the CABG (13.0% versus 12.9%; adjusted hazard ratio, 0.96 [95% CI, 0.55–1.66]; P =0.88) arms. In those without a CTO, PCI was associated with a significantly higher risk of major adverse cardiac and cerebrovascular events compared with CABG (adjusted hazard ratio, 1.61 [95% CI, 1.20–2.17]; P P =0.56; P interaction =0.31). CONCLUSIONS: The presence of a CTO did not significantly impact the treatment effect of PCI versus CABG at 3 years in patients with 3-vessel coronary artery disease. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02100722.
- 25 June 2020
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (27) , 2579-2588
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project
Aims: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas of Interventional Cardiology has been developed to map interventional practice across European Society of Cardiology (ESC) member countries. Here we present the main findings of a 16-country survey in which we examine the national availability of interventional infrastructure, human resource, and procedure volumes. Methods and results: Sixteen ESC member countries participated in the EAPCI Atlas survey. Interventional data were collected by the National Cardiac Society of each participating country. An annual median of 5131 [interquartile range (IQR) 4013–5801] diagnostic heart procedures per million people were reported, ranging from 7000 in Turkey and Germany. Procedure rates showed significant correlation (r = 0.67, P = 0.013) with gross national income (GNI) per capita. An annual median of 2478 (IQR 1690–2633) percutaneous coronary interventions (PCIs) per million people were reported, ranging from 3000 in Switzerland, Poland, and Germany. Procedure rates showed significant correlation with GNI per capita (r = 0.62, P = 0.014). An annual median of 48.2 (IQR 29.1–105.2) transcatheter aortic valve implantation procedures per million people were performed, varying from 100 per million people in Denmark, France, Switzerland, and Germany. Procedure rates showed significant correlation with national GNI per capita (r = 0.92, P < 0.001). Conclusion: The first report from the EAPCI Atlas has shown considerable international heterogeneity in interventional cardiology procedure volumes. The heterogeneity showed association with national economic resource, a reflection no doubt of the technological costs of developing an interventional cardiology service.
- 25 June 2020
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (27) , 2579-2588
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project
Aims: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas of Interventional Cardiology has been developed to map interventional practice across European Society of Cardiology (ESC) member countries. Here we present the main findings of a 16-country survey in which we examine the national availability of interventional infrastructure, human resource, and procedure volumes. Methods and results: Sixteen ESC member countries participated in the EAPCI Atlas survey. Interventional data were collected by the National Cardiac Society of each participating country. An annual median of 5131 [interquartile range (IQR) 4013–5801] diagnostic heart procedures per million people were reported, ranging from 7000 in Turkey and Germany. Procedure rates showed significant correlation (r = 0.67, P = 0.013) with gross national income (GNI) per capita. An annual median of 2478 (IQR 1690–2633) percutaneous coronary interventions (PCIs) per million people were reported, ranging from 3000 in Switzerland, Poland, and Germany. Procedure rates showed significant correlation with GNI per capita (r = 0.62, P = 0.014). An annual median of 48.2 (IQR 29.1–105.2) transcatheter aortic valve implantation procedures per million people were performed, varying from 100 per million people in Denmark, France, Switzerland, and Germany. Procedure rates showed significant correlation with national GNI per capita (r = 0.92, P < 0.001). Conclusion: The first report from the EAPCI Atlas has shown considerable international heterogeneity in interventional cardiology procedure volumes. The heterogeneity showed association with national economic resource, a reflection no doubt of the technological costs of developing an interventional cardiology service.
- Open Access
- 13 May 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-9
Index of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia
Background. The index of microcirculatory resistance is an invasive measure of coronary microvascular function that has to be calculated during maximal hyperemia, classically achieved with intravenous adenosine (IV). The aim of this study was to evaluate the use of intracoronary (IC) adenosine for the calculation of IMR. Methods and Results. 31 patients with stable coronary artery disease were included in the study. Coronary pressure and thermodilution measurements were obtained at rest and during maximal hyperemia using a pressure-temperature sensor-tipped coronary guidewire. Duplicate measurements were performed using first IC and then IV adenosine. Dispersion of transit times was comparable for IC and IV adenosine. IMR values based on IC vs IV adenosine showed a high level of agreement and an intraclass correlation coefficient of 0.90. Applying an upper normal limit of 25, misclassification of IMR using IC adenosine was seen in just one patient in whom IC adenosine resulted in a lower value. A simplified procedure based on a single bolus dose of saline did not change the level of agreement or the rate of misclassification. Conclusions. We found an excellent agreement between IMR values measured during hyperemia induced by IC as compared to IV adenosine. The use of IC adenosine may facilitate invasive assessment of microvascular function and is potentially time- and cost-saving with less patient discomfort as compared to IV infusion. The trail is registered with NCT03369184.
- 13 May 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-9
Open AccessIndex of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia
Background. The index of microcirculatory resistance is an invasive measure of coronary microvascular function that has to be calculated during maximal hyperemia, classically achieved with intravenous adenosine (IV). The aim of this study was to evaluate the use of intracoronary (IC) adenosine for the calculation of IMR. Methods and Results. 31 patients with stable coronary artery disease were included in the study. Coronary pressure and thermodilution measurements were obtained at rest and during maximal hyperemia using a pressure-temperature sensor-tipped coronary guidewire. Duplicate measurements were performed using first IC and then IV adenosine. Dispersion of transit times was comparable for IC and IV adenosine. IMR values based on IC vs IV adenosine showed a high level of agreement and an intraclass correlation coefficient of 0.90. Applying an upper normal limit of 25, misclassification of IMR using IC adenosine was seen in just one patient in whom IC adenosine resulted in a lower value. A simplified procedure based on a single bolus dose of saline did not change the level of agreement or the rate of misclassification. Conclusions. We found an excellent agreement between IMR values measured during hyperemia induced by IC as compared to IV adenosine. The use of IC adenosine may facilitate invasive assessment of microvascular function and is potentially time- and cost-saving with less patient discomfort as compared to IV infusion. The trail is registered with NCT03369184.
- Open Access
- 1 December 2019
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2019, 1-6
Changes in Index of Microcirculatory Resistance during PCI in the Left Anterior Descending Coronary Artery in Relation to Total Length of Implanted Stents
Aim. To investigate the relationship between stent length and changes in microvascular resistance during PCI in stable coronary artery disease (CAD). Methods and Results. We measured fractional flow reserve (FFR), index of microcirculatory resistance (IMR), and coronary flow reserve (CFR) before and after stenting in 42 consecutive subjects with stable coronary artery undergoing PCI with stent in the LAD. Patients that had very long stent length (38–78 mm) had lower FFR before stenting than patients that had long (23–37 mm) and moderate (12–22 mm) stent length (0.59 (±0.16), 0.70 (±0.12), and 0.75 (±0.07); ). FFR improved after stenting and more so in subjects with very long stent length compared to long and moderate stent length (0.27 (s.d ± 16), 0.15 (s.d ± 0.12), and 0.12 (s.d ± 0.07); for interaction = 0.013). Corrected IMR (IMRcorr) increased after stenting in subjects who had very long stent length, whereas IMRcorr was lower after stenting in subjects who had long or moderate stent length (4.6 (s.d. ± 10.7), −1.4 (s.d. ± 9,9), and −4.2 (s.d. ± 7.8); for interaction = 0.009). Conclusions. Changes in IMR during PCI in the LAD in stable CAD seem to be related to total length of stents implanted, possibly influencing post-PCI FFR. Larger studies are needed to confirm the relationship.- 1 December 2019
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2019, 1-6
Open AccessChanges in Index of Microcirculatory Resistance during PCI in the Left Anterior Descending Coronary Artery in Relation to Total Length of Implanted Stents
Aim. To investigate the relationship between stent length and changes in microvascular resistance during PCI in stable coronary artery disease (CAD). Methods and Results. We measured fractional flow reserve (FFR), index of microcirculatory resistance (IMR), and coronary flow reserve (CFR) before and after stenting in 42 consecutive subjects with stable coronary artery undergoing PCI with stent in the LAD. Patients that had very long stent length (38–78 mm) had lower FFR before stenting than patients that had long (23–37 mm) and moderate (12–22 mm) stent length (0.59 (±0.16), 0.70 (±0.12), and 0.75 (±0.07); ). FFR improved after stenting and more so in subjects with very long stent length compared to long and moderate stent length (0.27 (s.d ± 16), 0.15 (s.d ± 0.12), and 0.12 (s.d ± 0.07); for interaction = 0.013). Corrected IMR (IMRcorr) increased after stenting in subjects who had very long stent length, whereas IMRcorr was lower after stenting in subjects who had long or moderate stent length (4.6 (s.d. ± 10.7), −1.4 (s.d. ± 9,9), and −4.2 (s.d. ± 7.8); for interaction = 0.009). Conclusions. Changes in IMR during PCI in the LAD in stable CAD seem to be related to total length of stents implanted, possibly influencing post-PCI FFR. Larger studies are needed to confirm the relationship. - 1 February 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 253, 64-65
Shedding light on functional lesion severity — Is there a clinically relevant association between coronary anatomy and physiology?
- 1 February 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 253, 64-65
Shedding light on functional lesion severity — Is there a clinically relevant association between coronary anatomy and physiology?
- 24 February 2010
- Published by Wiley in Echocardiography
- Vol. 27 (2) , 139-145
Tricuspid Annular Velocity Assessed by Doppler Tissue Imaging as a Marker of Right Ventricular Involvement in the Acute and Late Phase after a First ST Elevation Myocardial Infarction
Background: Right ventricular (RV) involvement in patients with ST elevation myocardial infarction (STEMI) is a clinically important problem. The aim of this study was to evaluate the use of tricuspid annular velocity assessed by Doppler tissue imaging (DTI) as a marker of RV involvement in patients with a first STEMI. Methods: Seventy‐one patients with a first STEMI were examined by echocardiography before discharge and after 6 months. The patients were compared to 31 healthy subjects (HS). The diagnosis of RV infarction was based on the presence of ≥ 1 mm ST elevation in the right precordial ECG lead V4R. Tricuspid annular systolic and diastolic velocities using pulsed‐wave DTI were recorded at the RV free wall. Results: At day 1, tricuspid annular velocities were significantly reduced in patients with, compared to those without, ST elevation in V4R (11.1 vs. 13.7 cm/sec, 9.4 vs. 13.1 cm/sec and 14.1 vs. 15.9 cm/sec for systolic, early, and late diastolic velocities, respectively; P < 0.01). With a cutoff value for a tricuspid annular systolic velocity of 13 cm/sec, sensitivity and specificity for identifying patients with ST elevation in V4R were 89% and 71%, respectively. After 6 months, both tricuspid annular systolic and diastolic velocities in patients with RV infarction had increased significantly, but only tricuspid annular systolic velocity was still reduced compared to HS (12.3 vs. 14.7 cm/sec; P < 0.01). Conclusion: Tricuspid annular velocities assessed by DTI may be used as a marker of RV involvement in the acute and the late phase after a first STEMI. (ECHOCARDIOGRAPHY 2010;27:139‐145)
- 24 February 2010
- Published by Wiley in Echocardiography
- Vol. 27 (2) , 139-145
Tricuspid Annular Velocity Assessed by Doppler Tissue Imaging as a Marker of Right Ventricular Involvement in the Acute and Late Phase after a First ST Elevation Myocardial Infarction
Background: Right ventricular (RV) involvement in patients with ST elevation myocardial infarction (STEMI) is a clinically important problem. The aim of this study was to evaluate the use of tricuspid annular velocity assessed by Doppler tissue imaging (DTI) as a marker of RV involvement in patients with a first STEMI. Methods: Seventy‐one patients with a first STEMI were examined by echocardiography before discharge and after 6 months. The patients were compared to 31 healthy subjects (HS). The diagnosis of RV infarction was based on the presence of ≥ 1 mm ST elevation in the right precordial ECG lead V4R. Tricuspid annular systolic and diastolic velocities using pulsed‐wave DTI were recorded at the RV free wall. Results: At day 1, tricuspid annular velocities were significantly reduced in patients with, compared to those without, ST elevation in V4R (11.1 vs. 13.7 cm/sec, 9.4 vs. 13.1 cm/sec and 14.1 vs. 15.9 cm/sec for systolic, early, and late diastolic velocities, respectively; P < 0.01). With a cutoff value for a tricuspid annular systolic velocity of 13 cm/sec, sensitivity and specificity for identifying patients with ST elevation in V4R were 89% and 71%, respectively. After 6 months, both tricuspid annular systolic and diastolic velocities in patients with RV infarction had increased significantly, but only tricuspid annular systolic velocity was still reduced compared to HS (12.3 vs. 14.7 cm/sec; P < 0.01). Conclusion: Tricuspid annular velocities assessed by DTI may be used as a marker of RV involvement in the acute and the late phase after a first STEMI. (ECHOCARDIOGRAPHY 2010;27:139‐145)
- Open Access
- 29 June 2007
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 27 (5) , 305-308
Detection of left ventricular dysfunction by Doppler tissue imaging in patients with complete recovery of visual wall motion abnormalities 6 months after a first ST-elevation myocardial infarction
Highly available, noninvasive and cost-effective, echocardiography remains a keystone in the evaluation of patients with coronary artery disease (CAD). Echocardiographic assessment of cardiac function at rest and during dobutamine stress has direct clinical implications. Conventional echocardiographic parameters however, are partly based on visual interpretation of cardiac motion, thereby subject to interobserver variability, especially in patients with poor image quality. As a complement, myocardial velocity imaging techniques such as Doppler tissue imaging (DTI) offer quantitative markers of cardiac function. In the present study, we explored the feasibility and diagnostic value of DTI in the evaluation of left and right ventricular function, the presence of inducible ischemia and myocardial viability in patients with ST-elevation myocardial infarction (STEMI). In 90 patients with STEMI (64 men and 26 women aged 65±13 years) echocardiography was performed at day 1, 5–7 days and 6 months after admission. At day 5–7, dobutamine stress echocardiography (DSE) with wall motion analysis (WMA) was performed, followed by coronary angiography within 24 hours. Using DTI, systolic, early and late diastolic myocardial velocities were recorded near the mitral annulus at 4 left ventricular (LV) sites, and near the tricuspid annulus in the right ventricular free wall. The myocardial performance index (MPI), a Doppler-based, combined measure of systolic and diastolic function, was calculated as the sum of the isovolumic time intervals divided by the ejection time derived from DTI at the 4 LV sites. Forty-one aged-matched healthy subjects served as controls. In patients with complete normalization of conventional parameters of LV function at follow-up, peak systolic as well as early diastolic LV myocardial velocities were significantly reduced compared with those in healthy subjects, possibly reflecting a residual subendocardial damage. Using peak systolic velocity in the right ventricular (RV) free wall as a marker of RV function, sensitivity and specificity of DTI in identifying patients with electrocardographic signs of RV infarction (ST-elevation in ECG lead V4R) were 89% and 71%, respectively. Furthermore, peak RV systolic velocities remained reduced in patients with RV infarction, even after resolution of ECG changes and were still evident at 6 months’ follow-up. Use of the MPI as a marker of ischemia during DSE was shown to be feasible, and although the majority of patients did not achieve an optimal level of stress, relative changes in MPI between rest and peak stress offered reasonable diagnostic properties, superior to those of WMA. Sensitivity and specificity for detection of left anterior descending, left circumflex and right coronary artery disease were 80% and 87%, 59% and 80% and 85% and 72%, respectively. Finally, we found that MPI during low-dose dobutamine infusion exhibits a specific pattern, similar to that of WMA, predicting late recovery of LV systolic function. In conclusion, the use of DTI during echocardiography at rest and during dobutamine stress is feasible and allows evaluation of LV and RV function in the acute as well as the late phase after a STEMI. Furthermore, changes in MPI derived from DTI during DSE identify patients with residual CAD and predict late recovery of LV function, independently of age, troponin level and time to reperfusion treatment
- 29 June 2007
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 27 (5) , 305-308
Open AccessDetection of left ventricular dysfunction by Doppler tissue imaging in patients with complete recovery of visual wall motion abnormalities 6 months after a first ST-elevation myocardial infarction
Highly available, noninvasive and cost-effective, echocardiography remains a keystone in the evaluation of patients with coronary artery disease (CAD). Echocardiographic assessment of cardiac function at rest and during dobutamine stress has direct clinical implications. Conventional echocardiographic parameters however, are partly based on visual interpretation of cardiac motion, thereby subject to interobserver variability, especially in patients with poor image quality. As a complement, myocardial velocity imaging techniques such as Doppler tissue imaging (DTI) offer quantitative markers of cardiac function. In the present study, we explored the feasibility and diagnostic value of DTI in the evaluation of left and right ventricular function, the presence of inducible ischemia and myocardial viability in patients with ST-elevation myocardial infarction (STEMI). In 90 patients with STEMI (64 men and 26 women aged 65±13 years) echocardiography was performed at day 1, 5–7 days and 6 months after admission. At day 5–7, dobutamine stress echocardiography (DSE) with wall motion analysis (WMA) was performed, followed by coronary angiography within 24 hours. Using DTI, systolic, early and late diastolic myocardial velocities were recorded near the mitral annulus at 4 left ventricular (LV) sites, and near the tricuspid annulus in the right ventricular free wall. The myocardial performance index (MPI), a Doppler-based, combined measure of systolic and diastolic function, was calculated as the sum of the isovolumic time intervals divided by the ejection time derived from DTI at the 4 LV sites. Forty-one aged-matched healthy subjects served as controls. In patients with complete normalization of conventional parameters of LV function at follow-up, peak systolic as well as early diastolic LV myocardial velocities were significantly reduced compared with those in healthy subjects, possibly reflecting a residual subendocardial damage. Using peak systolic velocity in the right ventricular (RV) free wall as a marker of RV function, sensitivity and specificity of DTI in identifying patients with electrocardographic signs of RV infarction (ST-elevation in ECG lead V4R) were 89% and 71%, respectively. Furthermore, peak RV systolic velocities remained reduced in patients with RV infarction, even after resolution of ECG changes and were still evident at 6 months’ follow-up. Use of the MPI as a marker of ischemia during DSE was shown to be feasible, and although the majority of patients did not achieve an optimal level of stress, relative changes in MPI between rest and peak stress offered reasonable diagnostic properties, superior to those of WMA. Sensitivity and specificity for detection of left anterior descending, left circumflex and right coronary artery disease were 80% and 87%, 59% and 80% and 85% and 72%, respectively. Finally, we found that MPI during low-dose dobutamine infusion exhibits a specific pattern, similar to that of WMA, predicting late recovery of LV systolic function. In conclusion, the use of DTI during echocardiography at rest and during dobutamine stress is feasible and allows evaluation of LV and RV function in the acute as well as the late phase after a STEMI. Furthermore, changes in MPI derived from DTI during DSE identify patients with residual CAD and predict late recovery of LV function, independently of age, troponin level and time to reperfusion treatment